IHE
iShares U.S. Pharmaceuticals ETF
📎 Investment Objective
The iShares U.S. Pharmaceuticals ETF (IHE) seeks to track the investment results of an index composed of U.S. equities in the pharmaceutical sector.
Overview
ETF tracking iShares U.S. Pharmaceuticals ETF
Performance
Price Chart
Investment Summary
📎 Investment Objective
The iShares U.S. Pharmaceuticals ETF (IHE) seeks to track the investment results of an index composed of U.S. equities in the pharmaceutical sector.
🎯 Investment Strategy
The ETF employs a passive management strategy, attempting to replicate the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It invests primarily in companies that manufacture and market prescription or over-the-counter drugs and medications.
✨ Key Features
- Provides exposure to the U.S. pharmaceutical industry
- Diversified portfolio of large, established pharmaceutical companies
- Low expense ratio of 0.00%
- Suitable for long-term investors seeking healthcare sector exposure
⚠️ Primary Risks
- Concentration risk as the fund is focused on a single industry
- Susceptibility to regulatory changes and drug pricing pressures in the pharmaceutical sector
- Potential volatility due to the cyclical nature of the healthcare industry
- Lack of performance history as the fund has not yet completed a full year
👤 Best For
This ETF may be suitable for investors seeking long-term exposure to the U.S. pharmaceutical industry as part of a diversified portfolio. It may be of particular interest to investors with a higher risk tolerance who are comfortable with the inherent volatility of the healthcare sector.